The number of pups per litter was decreased at 173 mg/m 3 , as well as the number of implantation sites per female, and the number of fetuses born per implantation site
Results Liraglutide and GUB09-145 improve metabolic parameters in DIO mice Following 35 weeks of feeding, DIO mice showed significantly increased body weight (53.0 0.6 g, n = 45) compared to chow controls (32.1 0.2 g, n = 10, p 0.05) following treatment with vehicle, liraglutide or GUB09-145 as compared to baseline (Fig
Most clinical studies tracked fat loss for 48 weeks, with the most optimal effects at the end of treatment
Our current understanding is that both, circulating IGF-I levels and locally produced IGF-I, contribute to the maintenance of microcirculation functional and structural integrity, increasing NO bioavailability, decreasing reactive oxygen species (ROS) production, and exerting antiinflammatory, antiapoptotic, and pro-angiogenic effects
By enhancing insulin sensitivity and reducing glucose production in the liver, GLP-1 helps keep blood sugar levels stable, which is essential for overall health and well-being
